Inventor · disambiguated record
Mary Chaves
Also filed as: CHAVES MARY
8 granted patents·5 pending applications·33 citations·filing 2014–2025
82Inventor score
Files withAMGEN INC13
Top patents by PatentIndex Score
13 records- 0195US11827635B2Solid state formsAMGEN INC·Filed 2021·Granted Nov 28, 2023·11 cites·16 claims
- 0295US11236091B2Solid state formsAMGEN INC·Filed 2020·Granted Feb 1, 2022·21 cites·25 claims
- 0390US12398133B2Solid state formsAMGEN INC·Filed 2023·Granted Aug 26, 2025·1 cites·42 claims
- 0486US12421234B1Solid state formsAMGEN INC·Filed 2025·Granted Sep 23, 2025·0 cites·29 claims
- 0586US12415806B1Solid state formsAMGEN INC·Filed 2025·Granted Sep 16, 2025·0 cites·22 claims
- 0666US2024013869A1Predicting Shelf Life Stability of Lyophilized Drug ProductsAMGEN INC·Filed 2021·Application pending·0 cites
- 0762US2024140966A1Amorphous and crystalline forms of mcl-1 antagonistsAMGEN INC·Filed 2023·Application pending·0 cites
- 0859US2025115622A1Crystalline Forms Of An MCL-1 InhibitorAMGEN INC·Filed 2023·Application pending·0 cites
- 0958US2025122224A1Crystalline Salt and Solvate Forms Of Murizatoclax (AMG 397)AMGEN INC·Filed 2023·Application pending·0 cites
- 1054US12252486B2Solid state formsAMGEN INC·Filed 2020·Granted Mar 18, 2025·0 cites·54 claims
- 1153US10053452B2Crystalline forms of N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine salts and uses thereofAMGEN INC·Filed 2014·Granted Aug 21, 2018·0 cites·13 claims
- 1243US2022185791A1Polymorphs of a cardiac troponin activatorAMGEN INC·Filed 2020·Application pending·0 cites
- 1342US12187700B2Polymorphs and cocrystals of a cardiac troponin activatorAMGEN INC·Filed 2020·Granted Jan 7, 2025·0 cites·39 claims
Join the waitlist — get patent alerts
Get an alert when Mary Chaves files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →